ASX/ECS (ASX/ECS)

Australian Securities Exchange: ASX/ECS · AUD

A$0.01

+0.00 (0.0%)· Recorded snapshot

Market cap	8M
Revenue (ttm)	21M
Net income (ttm)	-1.9M
EPS (ttm)	-A$0.00
Shares out	1.6B
Volume	55,555
Beta	1.19

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 21M
Net income (ttm): -1.9M
EPS (ttm): -A$0.00
Market cap: 8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-8.4

P25 n/aP50 n/aP75 n/a

ROIC-1.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/ECS indicators

Market & fundamental data

Available fields

182

Groups with data

Currency

AUD

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-26
Enterprise value	AUD 13.2M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2018
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	AU0000052490
Last earnings date	2026-07-28
Last refreshed	2026-10-30
Market cap	AUD 8M
Next earnings date	2026-11-26
Price	AUD 0.01
Price currency	AUD
Sector	Healthcare
SIC code	2000
Stock price date	2026-10-29
Symbol	asx/ECS
Website	https://ecs-botanics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-26.18%
EV/EBITDA	22.67x
EV/Sales	0.63x
FCF / EV yield	-3.85%
FCF yield	-6.35%
P/(OCF - SBC) ratio	24x
P/B ratio	0.35x
P/OCF ratio	15.63x
P/S ratio	0.38x
Price / tangible book value	0.35x
Price/EBITDA ratio	13.76x
Sector forward P/E	34.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-2.45%
EBITDA margin	2.77%
Gross margin	47.19%
Operating margin	-2.45%
Pretax margin	-4.9%
Profit margin	-9.06%
ROA	-0.99%
ROA (5Y)	-0.42%
ROCE	-1.97%
ROE	-8.4%
ROE (5Y)	-4.06%
ROIC	-1.85%
ROIC (5Y)	-0.68%
SBC / revenue	0.85%
Tax / revenue	4.16%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Gross profit growth	76.2%
Gross profit growth (Q)	59.15%
Gross profit growth 3Y	23.14%
Gross profit growth 5Y	122.39%
Net income growth quarters	2
Net income growth years	1
OCF growth (QoQ)	-57.58%
OCF growth 3Y	8.36%
Revenue growth	8.55%
Revenue growth (Q)	0.48%
Revenue growth (QoQ)	-14.69%
Revenue growth 3Y	10.95%
Revenue growth 5Y	74.13%
Revenue growth quarters	3
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -1M
Depreciation and amortization	AUD 1.1M
EBIT	AUD -515,664
EBITDA	AUD 581,852
EPS	AUD -0.00
FCF per share	AUD -0.00
Financing cash flow	AUD 1.8M
Free cash flow	AUD -508,239
Free cash flow minus SBC	AUD -686,963
Gross profit	AUD 9.9M
Income taxes	AUD 874,785
Investing cash flow	AUD -1M
Net borrowing	AUD 89
Net cash flow	AUD 1.3M
Net income	AUD -1.9M
Operating cash flow minus SBC	AUD 333,606
Operating income	AUD -515,664
Revenue	AUD 21M
Stock-based compensation	AUD 178,724

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.02
Book value per share	AUD 0.01
Debt / EBITDA	11.83
Debt / equity	0.3
Interest coverage	-1
Long-term assets	AUD 12.8M
Long-term liabilities	AUD 3.5M
Net cash (debt)	AUD -5.2M
Net cash / market cap	-64.8%
Net debt / EBITDA	8.92
Net debt / equity	0.23
Piotroski F-Score	5
Property, plant and equipment	AUD 11.8M
Shareholders' equity	AUD 22.7M
Tangible book value	AUD 22.6M
Tangible book value per share	AUD 0.01
Total assets	AUD 31.6M
Total cash	AUD 1.7M
Total debt	AUD 6.9M
Total liabilities	AUD 8.9M
WACC	8.55%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.64
Current assets	AUD 18.8M
Current liabilities	AUD 5.5M
Current ratio	3.45
Inventory turnover	0.76
Net working capital	AUD 15.2M
Quick ratio	0.66
Working capital	AUD 13.4M
Working capital turnover	1.83

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-12.6%
Shareholder yield	-12.6%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	AUD 0.01
1D price change	0%
1Y price change	-37.5%
1Y return CAGR	-37.52%
1Y total return	-37.5%
20-day SMA	AUD 0.01
200-day SMA	AUD 0.01
3M price change	-16.67%
3M total return	-16.67%
3Y price change	-78.26%
3Y return CAGR	-39.86%
3Y total return	-78.26%
50-day SMA	AUD 0.01
50-day SMA vs 200-day SMA	50over200
52-week high	AUD 0.01
52-week high date	2025-12-15
52-week low	AUD 0.00
52-week low date	2026-07-02
5Y price change	-87.18%
5Y return CAGR	-33.69%
5Y total return	-87.18%
All-time high	AUD 0.09
All-time high date	2019-08-12
All-time low	AUD 0.00
All-time low date	2026-06-30
Average true range (ATR)	AUD 0.00
Average volume	842.3K
Beta (1Y)	1.28
Beta (2Y)	0.58
Beta (5Y)	1.19
Change from 52-week high	-37.5%
Change from 52-week low	66.67%
Change from all-time high	-94.25%
Change from all-time low	66.67%
Change from open	0%
Day's gap	0%
Dollar volume	AUD 278
High price	AUD 0.01
Low price	AUD 0.01
Monthly RSI	33.96
Open price	AUD 0.01
Previous close	AUD 0.01
Price vs 150-day SMA	-3.85%
Price vs 20-day SMA	-3.85%
Price vs 200-day SMA	-7.41%
Price vs 50-day SMA	-9.09%
Relative volume	0.07
RSI	42.82
Sharpe ratio	0.59
Sharpe ratio (3Y)	0.05
Sharpe ratio (5Y)	0.07
Sortino ratio	1.02
Sortino ratio (3Y)	0.13
Sortino ratio (5Y)	0.17
Volume	55.6K
Weekly RSI	46.19
YTD price change	-23.08%
YTD total return	-23.08%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1B
Shares change (QoQ)	20.99%
Shares change (YoY)	12.6%
Shares held by insiders	25.15%
Shares outstanding	1.6B

Deeper analysis on ASX/ECS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/ECS report

Is a complete ASX/ECS research report available?

No complete published report is available for asx/ECS (ASX/ECS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/ECS (ASX/ECS)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/ECS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/ECS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/ECS

Frequently asked questions